Capital raised by Zeo ScientifiX
1 Form D filing · first filed Nov 2025 · Davie, FL
Interim Chief Executive Officer and Chief Financial Officer
Signatory on Zeo ScientifiX's Form D filings · $500K raised across 1
Ian T. Bothwell is on file as Interim Chief Executive Officer and Chief Financial Officer at Zeo ScientifiX in Davie, FL. Zeo ScientifiX has 1 Form D filing on record, $500K raised in total. Ian T. Bothwell appears as a signatory on the company's filings.
Zofin is the company's lead clinical candidate, an acellular biologic therapeutic formulated from perinatal sources. It is currently advancing through Phase I/II clinical trials for its potential to treat conditions such as COVID-19, chronic obstructive pulmonary disease (COPD), and knee osteoarthritis.
